Filtered By:
Management: WHO
Therapy: Dialysis
This page shows you your search results in order of date.
Order by Relevance | Date
Total 157 results found since Jan 2013.
Potassium Disorders: Hypokalemia and Hyperkalemia
Am Fam Physician. 2023 Jan;107(1):59-70.ABSTRACTHypokalemia and hyperkalemia occur when serum potassium levels are less than 3.5 mEq per L or greater than 5.0 mEq per L, respectively. The World Health Organization recommends a potassium intake of at least 3,510 mg per day for optimal cardiovascular health. Hypokalemia is caused by decreased intake, renal losses, gastrointestinal losses, or transcellular shifts. Severe features of hypokalemia that require urgent treatment include a serum potassium level of 2.5 mEq per L or less, electrocardiography abnormalities, or neuromuscular symptoms. The underlying cause should be add...
Source: American Family Physician - January 23, 2023 Category: Primary Care Authors: Michael J Kim Christina Valerio Glynnis K Knobloch Source Type: research
Insights into induction of the immune response by the hepatitis B vaccine
World J Gastroenterol. 2022 Aug 21;28(31):4249-4262. doi: 10.3748/wjg.v28.i31.4249.ABSTRACTAfter more than four decades of hepatitis B virus (HBV) vaccine implementation, its safety and efficacy in preventing HBV infection have been proven and several milestones have been achieved. Most countries have included HBV immunization schedules in their health policies and progress has been made regarding universalization of the first HBV vaccine dose at birth. All of these actions have significantly contributed to reducing both the incidence of HBV infection and its related complications. However, there are still many drawbacks t...
Source: World Journal of Gastroenterology : WJG - September 26, 2022 Category: Gastroenterology Authors: Federico Alejandro Di Lello Alfredo Pedro Mart ínez Diego Mart ín Flichman Source Type: research
National Epidemiological Study about Hepatitis C Virus Infection among Dialysis Patients
Saudi J Kidney Dis Transpl. 2021 Nov-Dec;32(6):1715-1721. doi: 10.4103/1319-2442.352433.ABSTRACTThe World Health Organization estimates that 3% of the general population is infected with this virus. Hepatitis C remains the main viral infection in dialysis patients, and the severity of this infection is the risk of developing cirrhosis or hepatocarcinoma. We aim to determine the prevalence of hepatitis C in dialysis patients, to calculate the rate of hepatitis C virus (HCV) seroconversion, and to identify the risk factors for seroconversion. This is a nationwide multicenter observational study including all dialysis patient...
Source: Saudi Journal of Kidney Diseases and Transplantation - August 10, 2022 Category: Urology & Nephrology Authors: Meriam Hajji Samia Barbouch Rihab Manaa Khaoula Ajimi Fethi Ben Ben Hamida Rym Goucha Imen Gorsane Taieb Ben Abdallah Source Type: research
